These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 29121334)

  • 1. Pharmacotherapy of Apnea by Cannabimimetic Enhancement, the PACE Clinical Trial: Effects of Dronabinol in Obstructive Sleep Apnea.
    Carley DW; Prasad B; Reid KJ; Malkani R; Attarian H; Abbott SM; Vern B; Xie H; Yuan C; Zee PC
    Sleep; 2018 Jan; 41(1):. PubMed ID: 29121334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults.
    Roth T; White D; Schmidt-Nowara W; Wesnes KA; Niebler G; Arora S; Black J
    Clin Ther; 2006 May; 28(5):689-706. PubMed ID: 16861091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alertness and psychomotor performance effects of the histamine-3 inverse agonist MK-0249 in obstructive sleep apnea patients on continuous positive airway pressure therapy with excessive daytime sleepiness: a randomized adaptive crossover study.
    Herring WJ; Liu K; Hutzelmann J; Snavely D; Snyder E; Ceesay P; Lines C; Michelson D; Roth T
    Sleep Med; 2013 Oct; 14(10):955-63. PubMed ID: 23920422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized Controlled Trial of Solriamfetol for Excessive Daytime Sleepiness in OSA: An Analysis of Subgroups Adherent or Nonadherent to OSA Treatment.
    Schweitzer PK; Mayer G; Rosenberg R; Malhotra A; Zammit GK; Gotfried M; Chandler P; Baladi M; Strohl KP
    Chest; 2021 Jul; 160(1):307-318. PubMed ID: 33631141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Findings of the Maintenance of Wakefulness Test and its relationship with response to modafinil therapy for residual excessive daytime sleepiness in obstructive sleep apnea patients adequately treated with nasal continuous positive airway pressure.
    Inoue Y; Miki M; Tabata T
    Sleep Med; 2016; 27-28():45-48. PubMed ID: 27938918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modafinil improves daytime sleepiness in patients with mild to moderate obstructive sleep apnoea not using standard treatments: a randomised placebo-controlled crossover trial.
    Chapman JL; Kempler L; Chang CL; Williams SC; Sivam S; Wong KK; Yee BJ; Grunstein RR; Marshall NS
    Thorax; 2014 Mar; 69(3):274-9. PubMed ID: 24287166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modafinil for treatment of residual excessive sleepiness in nasal continuous positive airway pressure-treated obstructive sleep apnea/hypopnea syndrome.
    Black JE; Hirshkowitz M
    Sleep; 2005 Apr; 28(4):464-71. PubMed ID: 16171291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Armodafinil improves wakefulness and long-term episodic memory in nCPAP-adherent patients with excessive sleepiness associated with obstructive sleep apnea.
    Roth T; Rippon GA; Arora S
    Sleep Breath; 2008 Mar; 12(1):53-62. PubMed ID: 17874255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pitolisant for Daytime Sleepiness in Patients with Obstructive Sleep Apnea Who Refuse Continuous Positive Airway Pressure Treatment. A Randomized Trial.
    Dauvilliers Y; Verbraecken J; Partinen M; Hedner J; Saaresranta T; Georgiev O; Tiholov R; Lecomte I; Tamisier R; Lévy P; Scart-Gres C; Lecomte JM; Schwartz JC; Pépin JL;
    Am J Respir Crit Care Med; 2020 May; 201(9):1135-1145. PubMed ID: 31917607
    [No Abstract]   [Full Text] [Related]  

  • 10. Solriamfetol for the Treatment of Excessive Sleepiness in OSA: A Placebo-Controlled Randomized Withdrawal Study.
    Strollo PJ; Hedner J; Collop N; Lorch DG; Chen D; Carter LP; Lu Y; Lee L; Black J; Pépin JL; Redline S;
    Chest; 2019 Feb; 155(2):364-374. PubMed ID: 30471270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug therapy for obstructive sleep apnoea in adults.
    Mason M; Welsh EJ; Smith I
    Cochrane Database Syst Rev; 2013 May; 2013(5):CD003002. PubMed ID: 23728641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The combination of atomoxetine and dronabinol for the treatment of obstructive sleep apnea: a dose-escalating, open-label trial.
    Messineo L; Norman D; Ojile J
    J Clin Sleep Med; 2023 Jul; 19(7):1183-1190. PubMed ID: 36805833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjunct armodafinil improves wakefulness and memory in obstructive sleep apnea/hypopnea syndrome.
    Hirshkowitz M; Black JE; Wesnes K; Niebler G; Arora S; Roth T
    Respir Med; 2007 Mar; 101(3):616-27. PubMed ID: 16908126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The utility of patient-completed and partner-completed Epworth Sleepiness Scale scores in the evaluation of obstructive sleep apnea.
    Bhat S; Upadhyay H; DeBari VA; Ahmad M; Polos PG; Chokroverty S
    Sleep Breath; 2016 Dec; 20(4):1347-1354. PubMed ID: 27301400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atomoxetine improves sleepiness and global severity of illness but not the respiratory disturbance index in mild to moderate obstructive sleep apnea with sleepiness.
    Bart Sangal R; Sangal JM; Thorp K
    Sleep Med; 2008 Jul; 9(5):506-10. PubMed ID: 17900980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind, placebo-controlled study of armodafinil for excessive sleepiness in patients with treated obstructive sleep apnea and comorbid depression.
    Krystal AD; Harsh JR; Yang R; Rippon GA; Lankford DA
    J Clin Psychiatry; 2010 Jan; 71(1):32-40. PubMed ID: 20051221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and determinants of subjective sleepiness in healthy elderly with unrecognized obstructive sleep apnea.
    Sforza E; Pichot V; Martin MS; Barthélémy JC; Roche F
    Sleep Med; 2015 Aug; 16(8):981-6. PubMed ID: 26141008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of mirtazapine in obstructive sleep apnea syndrome.
    Carley DW; Olopade C; Ruigt GS; Radulovacki M
    Sleep; 2007 Jan; 30(1):35-41. PubMed ID: 17310863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solriamfetol for Excessive Sleepiness in Obstructive Sleep Apnea (TONES 3). A Randomized Controlled Trial.
    Schweitzer PK; Rosenberg R; Zammit GK; Gotfried M; Chen D; Carter LP; Wang H; Lu Y; Black J; Malhotra A; Strohl KP;
    Am J Respir Crit Care Med; 2019 Jun; 199(11):1421-1431. PubMed ID: 30521757
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of opioid, hypnotic and sedating medications on sleep-disordered breathing in adults with obstructive sleep apnoea.
    Mason M; Cates CJ; Smith I
    Cochrane Database Syst Rev; 2015 Jul; (7):CD011090. PubMed ID: 26171909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.